Stockscreener 앱 받기
391.02
0.26%
-1.03
시간 외 거래:
392.01
0.99
+0.25%
전일 마감가:
$392.05
열려 있는:
$392.13
하루 거래량:
1.31M
Relative Volume:
0.81
시가총액:
$100.25B
수익:
$11.39B
순이익/손실:
$3.64B
주가수익비율:
27.95
EPS:
13.99
순현금흐름:
$3.50B
1주 성능:
-1.04%
1개월 성능:
-16.52%
6개월 성능:
-17.59%
1년 성능:
-20.74%
1일 변동 폭
$389.38
$394.53
1주일 범위
$383.64
$396.13
52주 변동 폭
$362.50
$519.88
버텍스 파마슈티컬 Stock (VRTX) Company Profile
명칭
Vertex Pharmaceuticals Inc
전화
(617) 341-6393
주소
50 NORTHERN AVENUE, BOSTON, MA
VRTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
버텍스 파마슈티컬 Stock (VRTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-06 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-05-07 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2025-05-06 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-04-22 | 재개 | Cantor Fitzgerald | Overweight |
| 2025-02-12 | 업그레이드 | Canaccord Genuity | Sell → Hold |
| 2025-02-11 | 업그레이드 | Canaccord Genuity | Sell → Hold |
| 2025-01-30 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-12-20 | 재확인 | H.C. Wainwright | Buy |
| 2024-12-19 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-12-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-11-14 | 개시 | Citigroup | Buy |
| 2024-10-16 | 개시 | Scotiabank | Sector Perform |
| 2024-10-10 | 재개 | Raymond James | Mkt Perform |
| 2024-08-05 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2024-06-27 | 개시 | Redburn Atlantic | Buy |
| 2024-04-11 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2024-02-06 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-02-02 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2024-01-31 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2024-01-31 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2024-01-24 | 다운그레이드 | Canaccord Genuity | Hold → Sell |
| 2023-12-14 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2023-05-30 | 개시 | William Blair | Outperform |
| 2023-05-04 | 재개 | Piper Sandler | Overweight |
| 2023-03-21 | 개시 | Bernstein | Outperform |
| 2023-01-18 | 개시 | Canaccord Genuity | Hold |
| 2023-01-17 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-12-19 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-07-13 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-06-01 | 업그레이드 | Maxim Group | Hold → Buy |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-05-06 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-05-03 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2022-02-03 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-01-27 | 재확인 | JP Morgan | Overweight |
| 2022-01-27 | 재확인 | Morgan Stanley | Underweight |
| 2022-01-27 | 재확인 | RBC Capital Mkts | Outperform |
| 2022-01-27 | 재확인 | Stifel | Hold |
| 2022-01-27 | 재확인 | Wolfe Research | Outperform |
| 2022-01-20 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-11-19 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-09-09 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2021-07-20 | 다운그레이드 | SVB Leerink | Mkt Perform → Underperform |
| 2021-07-19 | 재개 | Wolfe Research | Outperform |
| 2021-07-01 | 개시 | Raymond James | Mkt Perform |
| 2021-06-11 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2021-02-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-02-02 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-30 | 개시 | Daiwa Securities | Outperform |
| 2020-11-30 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-20 | 개시 | Bernstein | Outperform |
| 2020-10-28 | 개시 | UBS | Buy |
| 2020-07-31 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-08 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-04-30 | 재확인 | H.C. Wainwright | Buy |
| 2020-04-28 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-03-04 | 개시 | Barclays | Overweight |
| 2020-01-31 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-11-19 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-11-12 | 개시 | SunTrust | Buy |
| 2019-10-17 | 재개 | BofA/Merrill | Buy |
| 2019-09-03 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-08-01 | 다운그레이드 | Needham | Buy → Hold |
| 2019-05-23 | 재개 | Citigroup | Buy |
| 2019-05-21 | 개시 | Credit Suisse | Outperform |
| 2019-04-12 | 개시 | Evercore ISI | In-line |
| 2019-03-26 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2019-03-19 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2019-02-06 | 다운그레이드 | Maxim Group | Buy → Hold |
모두보기
버텍스 파마슈티컬 주식(VRTX)의 최신 뉴스
Using Bollinger Bands to evaluate Vertex Pharmaceuticals IncorporatedWeekly Stock Analysis & Free Fast Gain Swing Trade Alerts - Newser
Is Vertex Pharmaceuticals Incorporated currently under institutional pressureJuly 2025 Sector Moves & Free AI Powered Buy and Sell Recommendations - خودرو بانک
Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance
Vertex Pharmaceuticals Incorporated stock trendline breakdownAnalyst Downgrade & Entry Point Confirmation Signals - Newser
Tools to monitor Vertex Pharmaceuticals Incorporated recovery probabilityTrade Analysis Summary & Capital Efficiency Focused Strategies - Newser
Price momentum metrics for Vertex Pharmaceuticals Incorporated explainedWeekly Trade Report & AI Forecasted Entry and Exit Points - Newser
Vertex Pharmaceuticals Incorporated Builds Base for Possible Rebound getLinesFromResByArray error: size == 0 - thegnnews.com
Visualizing Vertex Pharmaceuticals Incorporated stock with heatmapsJuly 2025 Sentiment & Free Reliable Trade Execution Plans - Newser
Risk adjusted return profile for Vertex Pharmaceuticals Incorporated analyzed2025 Biggest Moves & Daily Risk Controlled Trade Plans - Newser
Will earnings trigger a reversal in Vertex Pharmaceuticals IncorporatedPortfolio Performance Summary & Technical Confirmation Trade Alerts - Newser
Stock Analysis | Vertex Pharmaceuticals OutlookMixed Signals Amid Changing Market Dynamics - AInvest
Is Vertex Pharmaceuticals Incorporated stock reversal real or fake2025 Risk Factors & Safe Capital Growth Trade Ideas - Newser
What high frequency data says about Vertex Pharmaceuticals IncorporatedRate Cut & Daily Risk Controlled Trade Plans - Newser
When is the best time to exit Vertex Pharmaceuticals IncorporatedTrade Exit Summary & Technical Confirmation Trade Alerts - Newser
What does recent volatility data suggest for Vertex Pharmaceuticals IncorporatedJuly 2025 Spike Watch & Weekly Top Performers Watchlists - Newser
Can Vertex Pharmaceuticals Incorporated recover in the next quarterWeekly Trading Summary & Verified Momentum Watchlists - Newser
How to build a custom watchlist for Vertex Pharmaceuticals IncorporatedQuarterly Trade Summary & Fast Entry High Yield Tips - Newser
Order flow analysis tools used on Vertex Pharmaceuticals Incorporated2025 Technical Overview & Daily Stock Trend Watchlist - Newser
Will breakout in Vertex Pharmaceuticals Incorporated lead to full recoveryEarnings Summary Report & Safe Capital Growth Stock Tips - Newser
Should you wait for a breakout in Vertex Pharmaceuticals IncorporatedEntry Point & Safe Capital Growth Trade Ideas - Newser
Volatility clustering patterns for Vertex Pharmaceuticals IncorporatedDividend Hike & High Accuracy Investment Signals - Newser
How high can Vertex Pharmaceuticals Incorporated stock goTrade Signal Summary & Daily Technical Forecast Reports - Newser
Signal strength of Vertex Pharmaceuticals Incorporated stock in tech scannersPortfolio Return Summary & Weekly High Return Stock Opportunities - Newser
What technical models suggest about Vertex Pharmaceuticals Incorporated’s comeback - Newser
Vertex Pharmaceuticals Incorporated stock retracement – recovery analysisVolume Spike & Reliable Entry Point Alerts - Newser
Is Vertex Pharmaceuticals Incorporated trending in predictive chart models2025 Price Targets & Breakout Confirmation Trade Signals - Newser
Understanding Vertex Pharmaceuticals Incorporated’s price movementJuly 2025 Selloffs & Verified Trade Idea Suggestions - Newser
Will Vertex Pharmaceuticals Incorporated outperform the marketWeekly Trend Recap & Real-Time Buy Signal Alerts - Newser
버텍스 파마슈티컬 (VRTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.19%
1.29%
자본화:
|
볼륨(24시간):